SHALBY LIMITED Fair Value
SHALBY · Healthcare · Current price ₹153.66
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹84 | 4% ROE fading to 12% over ~3 yrs, on ₹93 book |
| Relative P/E | ₹224 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹85 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹173 | Street consensus 12-month target price |
Is SHALBY LIMITED undervalued?
DocStoX estimates the fair value of SHALBY LIMITED at ₹132 per share, versus the current market price of ₹154. That puts the stock about -13.8% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹84), Relative P/E (₹224), Graham floor (₹85), Analyst target (₹173). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹84 (bear) to ₹132 (base) to ₹224 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on SHALBY LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.